- Antibiotic resistance might cause up to 10 million death per year by 2050. (NYT)
- Is global warming causing a spike in poison ivy?
- Survey: 1 in 3 U.S. adults are interested in trying psychedelics like MDMA, known as ecstasy, or psilocybin, the naturally occurring compound in “magic mushrooms,” for their mental health.
- H.R.5608 would allow individuals to elect to receive contributions to a health savings account in lieu of reduced cost-sharing under health insurance obtained through a health insurance Exchange.
- Wisdom > From Larry Summers.
- Alex Tabarrok: drug companies need to make more money, not less.
Author: John C. Goodman
Thursday Links
- Who pays higher prices for medical care: commercial insurer’s or self-insured employer plans?
- Pharma’s case against PBMs.
- Roughly a quarter of children live in a one-parent home, more than in any other country. (NYT) Charles Murray made the same points a decade before the Gray Lady discovered the problem.
- Only about one in five Americans think abortion should be allowed after the state of pregnancy in which the fetus is viable outside the womb (about 23 or 24 weeks).
Wednesday Links
- Covid booster tested mice – what we know.
- The cost of Biden’s attempts to undo Trump’s deregulations: 15.3% of household income for the bottom one-fifth of the income distribution, but only 2.2% for the top fifth.
- Gene Steuerle: it’s not clear there has been any slow down in the growth of health care spending.
- Over the last half-century or so, the median household has seen income gains of less than 1% per year.
IRS Freezes Giveaway Program Before the Goodman Institute Makes Its Claim
Businesses, including nonprofit organizations and churches, have been able to seek up to $26,000 for each employee on their payrolls if they can show that their operations were fully or partly suspended in 2020 or part of 2021, and report a significant decline in their revenues during that time. Before the moratorium was announced, they had until 2025 to file claims.
Why didn’t everybody get in on this deal?